|Articles|May 1, 1999

May 1999
Volume 5
Issue 5

Course and Cost of Treatment for Depression with Fluoxetine, Paroxetine, and Sertraline

Author(s)James M. Russell, MD, Ernst R. Berndt, PhD, Robert Miceli, PhD

Download PDF: Course and Cost of Treatment for Depression with Fluoxetine, Paroxetine, and Sertraline

Articles in this issue

over 26 years ago

Article

Relationship between Primary Payer and Use of Proactive Immunization Practices: A National Survey

over 26 years ago

Article

Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication Reviews

over 26 years ago

Article

Project LEAP of New Jersey: Lower Extremity Amputation Prevention in Persons with Type 2 Diabetes

over 26 years ago

Article

Quality of Care for Chronic Illness in Primary Care: Opportunities for Improvement in Process and Outcome Measures

over 26 years ago

Article

Assessment of Patient Satisfaction with a Formulary Switch from Omeprazole to Lansoprazole in Gastroesophageal Reflux Disease Maintenance Therapy

over 26 years ago

Article

Overview of Platelet Glycoprotein IIb/IIIa Receptor Antagonist Treatment in the Management of Coronary Interventions and Acute Ischemic Coronary Syndromes

over 26 years ago

Article

Benign Prostatic Hyperplasia: An Overview for Pharmacists

over 26 years ago

Article

Correspondence regarding, "How Should Managed Care Treat Onychomycosis?"

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Course and Cost of Treatment for Depression with Fluoxetine, Paroxetine, and Sertraline

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

New Dermatologic Therapies Make Waves at Maui Derm 2026

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment